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Abstract
Prenyl flavonoids are widely distributed in plant foods and have attracted appreciable attention in relation to their potential
benefits for human health. Prenylation may enhance the biological functions of flavonoids by introducing hydrophobic
properties in their basic structures. Previously, we found that 8-prenyl naringenin exerted a greater preventive effect on
muscle atrophy than nonprenylated naringenin in a mouse model. Here, we aimed to estimate the effect of prenylation on
the bioavailability of dietary quercetin (Q). The cellular uptake of 8-prenyl quercetin (PQ) and Q in Caco-2 cells and C2C12
myotube cells was examined. Prenylation significantly enhanced the cellular uptake by increasing the lipophilicity in both
cell types. In Caco-2 cells, efflux of PQ to the basolateral side was <15% of that of Q, suggesting that prenylation
attenuates transport from the intestine to the circulation. After intragastric administration of PQ or Q to mice or rats, the
area under the concentration-time curve for PQ in plasma and lymph was 52.5% and 37.5% lower than that of Q,
respectively. PQ and its O-methylated form (MePQ) accumulated at much higher amounts than Q and O-methylated Q in
the liver (Q: 3400%; MePQ: 7570%) and kidney (Q: 385%; MePQ: 736%) of mice after 18 d of feeding. These data
suggest that prenylation enhances the accumulation of Q in tissues during long-term feeding, even though prenylation per
se lowers its intestinal absorption from the diet. J. Nutr. 143: 1558–1564, 2013.
Introduction
Prenyl flavonoids possess a C5 isoprenoid unit in a diphenyl-
propane structure. Prenyl flavonoids are present in Legumino-
sae, Moraceae, and Asteraceae (1) and are mainly distributed in
the roots, leaves, and seeds (1,2). Recent studies have suggested
that prenyl flavonoids exert biological functions. For example,
the prenyl flavonoid icaritin has been shown to prevent growth
of carcinoma cells by inducing cell-cycle arrest (3). Prenyl
flavanones extracted from the roots of Sophora flavescens were
found to possess antibacterial and antiandrogen activities (4).
Prenyl flavones from Psoralea corylifolia have been demon-
strated to suppress the production of NO in nerve cells (5).
Prenylation has been shown to enhance the estrogenic activity
and tyrosinase activity of naringenin (6) and luteolin (7),
respectively. These observations imply unique properties of
prenyl flavonoids in in vitro cell culture systems.
Our previous study using 8-prenyl naringenin (PN)8 (8) sug-
gested that the biological potential of prenyl flavonoids could be
due to their greater absorption by the body and efficient accumu-
lation in target tissues. However, it remains unknown whether
prenylation enhances the bioavailability of flavonoids for intes-
tinal absorption and tissue accumulation in vivo.
Prenylation at the 8-position in flavonoids is found in plants
and an enzyme that introduces a prenyl group to flavonoids at
the 8-position was recently identified (9). In fact, in the plant
kingdom, the 8-position is prenylated in naringenin (10),
kaempferol (11), and isoflavones (12). PN is present in hops
and beer (10). Recently, 8-prenyl quercetin (PQ) was found in
Desmodium caudatum (13), which is used as an ingredient in
traditional foods in Japan. Therefore, we selected PQ to clarify
the effect of prenylation on the bioavailability of quercetin (Q)
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(Supplemental Fig. 1). Q is a common flavonoid relevant to
studies of intestinal absorption and metabolic conversion. The
mechanism of intestinal transport for dietary Q present as Q
glycosides in plant foods has been well documented in intestinal
epithelial cell lines and animal models (14). It is also known
that glucuronide-/sulfate-conjugated metabolites with or with-
out O-methylation are exclusively detected in human plasma
after intake of Q-rich foods (15,16). Q metabolites are also
present in the lymph in rats (17). Therefore, it is likely that blood
and lymph can deliver Q metabolites to target tissues (18,19).
Previous reports have suggested that dietary icaritin and PN are
transported in human plasma (20,21) as conjugated metabolites
in a similar way to nonprenyl flavonoids (22,23). Nevertheless,
studies focusing on the mechanism of the intestinal absorption
and tissue accumulation of prenyl flavonoids are lacking.
We examined how prenylation affects the intestinal absorp-
tion and tissue accumulation of Q using monolayer cultures of
Caco-2 cells and C2C12 myotube cells. We also measured the
PQ concentrations in plasma and lymph of mice and rats. In
addition, the amounts of PQ, Q, and their metabolites in various
tissues were determined after mice were fed a diet containing Q
or PQ for 18 d. The combination of these in vitro and in vivo
studies may provide clues to clarify the effects of prenylation on
the modulation of the bioavailability of dietary Q.
Materials and Methods
Materials. Q (3,3#,4#,5,7-pentahydroxyflavone) was purchased from
Nacalai. Kaempferol, isorhamnetin (I), and 3,3#,4#,5,7-pentamethoxy-
flavone were obtained from Extrasynthase. PQ, 8-prenyl I, and PN were
synthesized by our research team (24). Other reagents were of the highest
grade available from commercial sources.
Measurement of the partition coefficient in the octanol/water
phase. The method for measurement of the partition coefficient in the
octanol/water phase was carried out as previously described (25) with
slight modifications. A methanol solution (100 mL) of 300mmol/L PQ or
1mmol/LQwas placed in a test tube and the solvent was removed with a
nitrogen stream. The residue was dispersed in 100 mL of 50 mmol/LTris-
HCl (pH 7.4) and 100 mL of 1-octanol. The solution was vortex-mixed
for 1 min, followed by centrifugation (16,000 3 g, 4C, 5 min). The
concentrations of each flavonoid in the water and octanol phases were
measured by HPLC as described below. The log partition coefficient in
octanol/water phases (Po/w) value was calculated using the following
equation:
logPo=w ¼ log10½flavonoid in octanol layer ðmMÞ=
flavonoid inTris-HCl layer ðmMÞ:
Cellular uptake and permeability of PQ and Q in Caco-2 cells. The
cellular uptake and permeability in Caco-2 cells were ascertained as
previously described (26). Briefly, Caco-2 cells at passages 42–56 were
seeded at 1 3 105 cells/cm2 and cultured for 20–22 d until the
experiments were performed. The inserts were washed with HBSS (pH
7.4) for 30 min in a CO2 incubator. Subsequently, 50 mmol/L PQ or Q in
DMSO solution was diluted with HBSS and the final concentration was
adjusted to 50 mmol/L. The test solutions were added to the apical side of
Caco-2 monolayers and incubated for 0.25, 1, 2, 4, or 6 h at 37C. After
the incubation, the apical and basolateral solutions were collected.
Cellular extracts were prepared by incubating the whole inserts with
methanol containing 0.5% acetic acid for 30 min. The apical and
basolateral solutions and the cellular extracts were evaporated using a
Centrifugal Vaporizer (CVE-100; Tokyo Rikakikai). The residues were
mixed with 0.1 mL of 100 mmol/L acetate buffer (pH 5.0), 0.22 mL of
50 mmol/L ascorbic acid solution, and 100 U of b-glucuronidase type
H-1 solution in 100 mmol/L acetate buffer (0.1 mL, pH 5.0) and
incubated at 37C for 30 min. After centrifugation (90003 g for 10 min
at 4C), aglycones were extracted 3 times in ethyl acetate by sonication
for 1 min using an XL2020 Ultrasonic Processor (Astrason) at level 10.
Before the extraction, 14 pmol of 3,3#,4#,5,7-pentamethoxyflavone (for
PQ) or kaempferol (for Q) was added to the suspensions as an internal
standard. After centrifugation (9000 3 g for 10 min at 4C), the
supernatants were collected, evaporated under nitrogen gas, and
dissolved in 70 mL of methanol containing 0.5% phosphoric acid.
Flavonoids were determined by HPLC as described below.
Uptake of PQ and Q in myotube C2C12 cells. We determined the
uptake of PQ or Q in the mouse myoblast cell line C2C12 (American Type
Culture Collection). The cell culture and differentiation method were
described in a previous study (8). PQ or Q in DMSO solution (10 mmol/L)
was diluted with culture medium (2% horse serum in DMEM) and the
final concentration was adjusted to 10 mmol/L . To estimate the effect of
inhibition of ATP production on efflux transportation, 10 mmol/L sodium
azide was added at 15 min before flavonoid treatment. The protein
concentration of the cell suspensions was measured using the Bradford
assay (27). The extraction and analyses were performed according to the
uptake and permeability experiment using Caco-2 cells as described above.
Animal experiments. All experimental protocols were in accordance
with the Guidelines for the Care and Use of Laboratory Animals set by
the Graduate School of the Institute of Health Biosciences of the
University of Tokushima. The protocol was approved by the Committee
on Animal Experiments of the University of Tokushima (permit no.
11013). All surgery was performed under anesthesia using sodium
pentobarbital or diethyl ether. All efforts were made to minimize the
suffering of the animals.
Administration of PQ or Q to mouse stomachs and determination
of the plasma concentration of their metabolites: single dose.
Administration of PQ or Q to the stomach and blood collection was
completed as previously described (8). Seven-week-old male C57/BL6
mice (Japan SLC) were housed in a room maintained at 23 6 1C on a
12-h-light/-dark cycle. They were allowed free access to AIN-93M diet
(8) with no modification (Oriental Yeast) and water for 1 wk. Before
administration, the mice were deprived of food for 18 h but had free
access to water. PQ or Q dissolved in propylene glycol (5 g/L) was
administered (50 mg/kg body weight) to mice by a gastric feeding tube.
Sample preparation, deconjugation, and flavonoid extraction were
performed as previously described (8). PN [for PQ and O-methylated
prenyl quercetin (MePQ)] or kaempferol [for Q and O-methylated
quercetin (MeQ)] was added to the sample as an internal standard.
Flavonoids were determined by HPLC as described below.
Administration of PQ or Q to rat stomachs and determination of
their metabolites in lymph fluid: single dose.Male Wistar rats (10–
14 wk) were purchased from Japan SLC. The rats were allowed free
access to drinking water and AIN-93M diet with no modification
(Oriental Yeast). Under anesthesia, cannulation of the thoracic lymph
duct, along with introduction of a gastric tube for sample administra-
tion, was undertaken as previously described (17). Rats were infused
with 1 mL of PQ solution or Q solution in propylene glycol at 50 mg/kg
body weight via the gastric tube, followed by continuous infusion of
glucose-NaCl solution. Lymph fluid was collected in tubes containing
10 mmol/L sodium-EDTA solution to avoid coagulation. The resulting
aglycones were determined by HPLC analyses employing the same
method described for the plasma analyses.
Determination of PQ, Q, and their O-methylated metabolites in
the plasma and tissues of mice: long-term feeding. PQ or Q (0.2%
wt:wt) wasmixed with AIN-93Mdiet (Oriental Yeast Co.). The cellulose
content was reduced to adjust the composition of the other nutrients.
The diets were given to 7-wk-oldmale C57/BL6mice (Japan SLC) for 18 d.
Tissue samples were collected and stored at –80C under nitrogen gas
until HPLC analyses. Sample preparation, deconjugation, and flavonoid
extraction were performed as previously described (8). PN (for PQ and
MePQ) or kaempferol (for Q and MeQ) was added to the samples as an
internal standard.
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HPLC analyses for determination of Q, PQ, and their O-methylated
forms. PQ and Q were determined by reference to their respective standard
curves. MePQ and MeQ were determined using the standard curve for
8-prenyl isorhamnetin and I, respectively. A Cadenza 3-mm CD-C18
HPLC column (1503 4.6 mm; Imtakt) was employed. The flow rate was
set at 1.0 mL/min. Because each sample had specific interference peaks in
the HPLC chromatogram, we selected an optimum detection condition
for each experiment, as shown in Supplemental Table 1. The analytical
conditions were defined as follows. By monitoring the chromatogram
from each sample (e.g., plasma, lymph, cell, tissues) without Q or PQ
treatment, we confirmed the retention time and wavelength of poten-
tially interfering peaks. Subsequently, we developed analytical condi-
tions for separating the interfering peaks from the peaks of Q (MeQ) and
PQ (MePQ). It was confirmed that no interference peaks overlapped
with the peaks for the determination.
Statistical analyses. Data are presented as the means 6 SEMs of at
least 3 independent determinations for each experiment.We analyzed the
equality of variance by Levenes test. If there was a significant difference
(P < 0.05), each value was converted to the logarithmic value. Data were
analyzed by 2-way (methylation 3 prenylation) or 3-way (methylation
3 prenylation3 time) ANOVA as appropriate.When an interaction was
significant, means were compared using Tukeys test. Differences were
considered significant at P < 0.05. In the time course experiments (Caco-
2, C2C12, plasma, and lymph), means were compared at each time
point. The analyses were performed by PASS Statistics 17.0 (IBM).
Results
Effect of prenylation of Q on hydrophobicity. Hydropho-
bicity was measured using the Po/w. The logPo/w values of PQ and
Q were calculated to be 3.73 and 2.53, respectively. Prenylation
increased the hydrophobicity of Q.
Accumulation and permeability of PQ in Caco-2 cells. We
compared the permeability of PQ with that of Q in Caco-2 cells
(Fig. 1). The amounts of PQ and Q in the apical solutions were
decreased within 1 h after addition and thereafter the efflux of Q
to the apical side was higher than that of PQ (Fig. 1A) (P < 0.05).
PQ and Q were incorporated into Caco-2 cells and the amount
of PQ incorporated into the cells was higher than that of Q from
1 to 6 h of incubation (P < 0.05) (Fig. 1B). Figure 1C shows the
amounts of PQ and Q in the solution in which a small amount of
PQ appeared during incubation for 6 h, and its concentration
was lower than that of Q from 1 to 6 h of incubation (P < 0.05).
This phenomenon indicated that the efflux of PQ from the cells
to the basolateral side was less than that of Q. The amounts of
MePQ andMeQ did not differ from or were lower than those of
the respective non-O–methylated PQ and Q, respectively. These
findings suggested that O-methylation was a minor pathway in
the metabolism of PQ and Q in this enterocyte model. Taken
together, prenylation increased the cellular uptake of Q from the
apical side and decreased the efflux of Q to the basolateral side,
resulting in higher accumulation in epithelial cells.
Uptake of PQ in mouse C2C12 myotube cells. We measured
the uptake of PQ in C2C12 myotube cells as a potential cellular
target of prenylated flavonoids (8). The conjugation reaction of
flavonoids was not found in C2C12 cells (data not shown), so we
did not employ a deconjugation treatment for this cell culture
experiment. The results of the cellular uptake are shown in
Figure 2A. PQ was incorporated into cells and/or associated
with cellular membranes at a much higher amount than Q after
0.25, 1, and 2 h of incubation (P < 0.05) (Fig. 2A). PQ and Q
were converted to their O-methylated forms and the amount of
MePQ in cells was higher than that of MeQ from 1 to 24 h of
incubation (P < 0.05). O-methylation was a major pathway for
the cellular metabolism of PQ in myotubes, becauseO-methylated
products accumulated at a higher amount than intact PQ after
incubation of cells with PQ from 4 to 24 h (P < 0.05). Next, we
confirmed the contribution of ATP to the efflux of PQ using
sodium azide (Fig. 2B). The sum of Q and MeQ in C2C12 cells
was increased by sodium azide (P < 0.05), which was a different
pattern from that seen with PQ treatment. These findings sug-
gested that PQ was less susceptible to elimination than Q via an
energy requirement pathway.
Transport of PQ into the blood and lymph circulation after
administration in rodent stomachs at a single dose. PQ or
Q was administered to mice and the plasma concentration was
analyzed by HPLC (Fig. 3A). Pharmacokinetics were calculated
FIGURE 1 Permeability of PQ and Q in Caco-2 cells. PQ or Q was
incubated for 0.25, 1, 2, 4, or 6 h in apical solutions (A), cells (B), and
basolateral solutions (C). Data are means 6 SEMs, n = 5. Data were
log-transformed before ANOVA; prenylation (P), methylation (M), and
time (T). Means at a time without a common letter differ, P , 0.05.
MePQ, O-methylated prenyl quercetin; MeQ, O-methylated quercetin;
PQ, 8-prenyl quercetin; Q, quercetin.
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and are summarized in Table 1. At 30 min after administration,
the plasma concentrations of PQ, MePQ, Q, and MeQ reached
the highest amount (termed Cmax). Prenylation decreased the
mean Cmax values in plasma (P < 0.001). The amount of trans-
port into the blood circulation was estimated by the area under
the concentration-time curve (AUC). The AUC of MePQ (7.63
mmol/L  h) was lower than that of MeQ (229 mmol/L  h) (P <
0.05). The MeQ concentration was higher than that of MePQ
during the experiment (P < 0.05).
To determine the amount of flavonoids in lymph, PQ or Q
was injected into rat stomachs (Fig. 3B). At 30 min after
administration, PQ and MePQ as well as Q and MeQ appeared
in the lymph circulation. The lymph concentration of MePQ
was lower than that of MeQ during the experiment (P < 0.05).
Pharmacokinetics were calculated and are summarized in Table
2. Prenylation and methylation affected the Cmax in lymph (P <
0.001). The AUC values of PQ andMePQwere also lower than
those of their nonprenyl forms, Q and MeQ, respectively (P <
0.01). These results demonstrated that prenylation reduced
the transport from the digestive tract to the blood and/or
lymph circulation. In other words, prenylation reduced the
O-methylation of Q in metabolic pathways during absorption
from enterocytes.
Plasma concentration and tissue accumulation of PQ after
long-term feeding. The plasma total concentrations of Q,
MeQ, PQ, and MePQ after deconjugation treatment were 2.40,
3.96, 1.63, and 1.16 mmol/L, respectively (Table 3). The plasma
concentration of MePQ was lower than that of MeQ after
long-term feeding (P < 0.05). Prenylation increased tissue
accumulation in liver and kidney (P < 0.001). Prenylation and
methylation did not affect tissue accumulation in muscle and
heart (P > 0.10). Tissue accumulation in brain was affected by
methylation as well as the interaction (prenylation 3 methyla-
tion) (P < 0.0001). In brain, the amounts ofMQ andMePQwere
higher than those of their respective nonmethylated forms (P <
0.05). Contrary to the concentrations in plasma and lymph,
prenylation was likely to elevate tissue accumulation of Q.
Discussion
We found that prenylation at the 8-position affected the intes-
tinal absorption, internal circulation, and tissue distribution
of Q. PQ is found in D. caudatum (13), and 8-prenylflavonoids
FIGURE 2 Uptake of PQ and Q in mouse C2C12 myotubes. (A) Q or
PQ (10 mmol/L) was administered to cells for the times indicated. Data
are means6 SEMs, n = 3. Data were log-transformed before ANOVA.
Means at a time without a common letter differ, P, 0.05. (B) Effect of
NaN3 on the efflux of PQ from C2C12 cells was determined. The
amount of cellular uptake was calculated as the sum of Q and MeQ or
PQ and MePQ. Data are shown as the percent of NaN3-free condition
of the each flavonoid and are means 6 SEMs, n = 3. Data were log-
transformed before ANOVA; prenylation (P), methylation (M), NaN3
treatment (N), and time (T). Means without a common letter differ,
P , 0.05. MePQ, O-methylated prenyl quercetin; MeQ, O-methylated
quercetin; PQ, 8-prenyl quercetin; Q, quercetin.
FIGURE 3 Concentration of PQ and Q in plasma and lymph after
their administration into rodent stomachs as a single dose. PQ or Q
was administered to mice (A, plasma) and rats (B, lymph). Data are
means 6 SEMs, n = 5. Data were log-transformed before ANOVA;
prenylation (P), methylation (M), and time (T). Means at a time without
a common letter differ, P , 0.05. MePQ, O-methylated prenyl
quercetin; MeQ, O-methylated quercetin; PQ, 8-prenyl quercetin; Q,
quercetin.
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(including PQ) are known to be distributed in plants used as
food ingredients (10–12). Therefore, we investigated the effect
of prenylation on the bioavailability of Q by comparing the
characteristics of PQ with those of intact Q.
Prenylation increases the hydrophobicity of Q as evaluated by
logPo/w. Flavonoid aglycones have been suggested to be incorpo-
rated into cells by simple diffusion controlled by the hydrophobicity
of substances and their affinity for hydrophobic phospholipid
bilayer membranes (28). Therefore, prenylation may enhance
the cellular uptake of flavonoids, resulting in their biological
activities in in vitro model systems (6,7). Prenylation enhanced
the uptake of Q in myotube cells (Fig. 2A).
In the Caco-2 cell line, the amount of PQ in the epithelial cells
was higher than that of Q, whereas a lower amount of PQ
existed on the basolateral side compared with Q (Fig. 1).
Although the lifespan of enterocytes is only a few days, the time
to maximum concentration of each flavonoid in blood plasma as
well as lymph is <24 h. These observations suggest that the
shedding of intestinal cells has little effect on the transport of
flavonoids to the circulation. Although the lipid condition on the
basolateral side would attenuate efflux of PQ from intestinal
cells, we considered that efflux of PQ to the basolateral side was
lower than that of Q, even if lipids existed in the fluid, because
the PQ concentration in lymph and plasma after a single dose
was lower than that of Q (Fig. 3). Q is subjected to the actions of
phase-II enzymes in epithelial cells during intestinal absorption
(26,29). The resulting glucuronide and/or sulfate conjugates are
released to the basolateral side through ATP-binding cassette
transporters (ABC transporters) (30–32). ATP inhibition in-
creased the amount of Q, but not PQ, in C2C12 cells (Fig. 2B).
Therefore, it is likely that PQ is not well transported through
ATP-dependent transportation systems. Similar to the case for
C2C12 cells, intestinal cells may not transport PQ well from
enterocytes to the internal circulation (blood and lymph) via
ATP-dependent transportation systems (e.g., ABC transporters).
PQ was circulated as its conjugated metabolites in blood and
lymph at a lower amount than Q (Fig. 3). These data are in
accordance with our previous study using PN (8). In general,
flavonoids undergo conjugation in enterocytes and hepatocytes
before entering the circulation. Although studies have demon-
strated that prenyl flavonoids are metabolized by conjugation
enzymes (20,21,23), substitution of the prenyl group in the
8-position might prevent the activity of conjugation enzymes.
However, the effect of prenylation on conjugation enzymes was
not clarified in the present study, because we introduced a
deconjugation treatment in the quantitative analyses.
Previously, we discovered that orally administered Q can
enter the lymph circulation (17). Although we were draining
TABLE 1 Pharmacokinetic parameters in plasma after intra-
gastric administration of PQ or Q to mice at 50 mg/kg body
weight1
Variable Cmax Tmax AUC
mmol/L h mmol/L  h
Q 10.2 6 2.58 0.25 6 0.00b 68.7 6 10.5ab
MeQ 7.18 6 2.05 5.10 6 1.78a 229 6 38.5a
PQ 2.43 6 0.67 0.80 6 0.12ab 36.1 6 8.33b
MePQ 0.43 6 0.29 0.90 6 0.29ab 7.63 6 3.64c
ANOVA P value
Prenylation ,0.01 0.18 ,0.01
Methylation 0.15 ,0.05 0.26
Prenylation 3 methylation 0.76 ,0.05 ,0.01
1 Data are means 6 SEMs, n = 5. Data from Tmax, and AUC were log transformed
before ANOVA. Labeled means in a column without a common letter differ, P , 0.05.
Cmax, maximum concentration; MePQ, O-methylated prenyl quercetin; MeQ, O-
methylated quercetin; PQ, 8-prenyl quercetin; Q, quercetin; Tmax, time to maximum
concentration.
TABLE 2 Pharmacokinetic parameters in lymph after intragastric
administration of PQ or Q to rat at 50 mg/kg body weight1
Variable Cmax Tmax AUC
mmol/L h mmol/L  h
Q 2.51 6 0.41 0.50 6 0.00b 27.5 6 4.01a
MeQ 0.92 6 0.15 15.7 6 4.83a 25.3 6 4.80a
PQ 1.18 6 0.37 1.20 6 0.12b 10.3 6 1.92b
MePQ 0.20 6 0.07 0.80 6 0.12b 2.25 6 0.32c
ANOVA P value
Prenylation ,0.01 0.06 ,0.01
Methylation ,0.01 ,0.01 ,0.01
Prenylation 3 methylation 0.15 ,0.01 ,0.01
1 Data are means 6 SEMs, n = 5. Data were log transformed before ANOVA. Labeled
means in a column without a common letter differ, P , 0.05. Cmax, maximum
concentration; MePQ, O-methylated prenyl quercetin; MeQ, O-methylated quercetin;
PQ, 8-prenyl quercetin; Q, quercetin; Tmax, time to maximum concentration.
TABLE 3 Tissue distribution of PQ or Q in mice after 18 d of feeding of each flavonoid-containing diet1
Variable Liver Kidney Muscle Heart Brain Plasma
nmol/g wet tissue nmol/g wet tissue nmol/g wet tissue nmol/g wet tissue nmol/g wet tissue mmol/L
Q fed
Q 0.29 6 0.07 0.20 6 0.07 0.23 6 0.01 0.12 6 0.01 0.04 6 0.00a 2.40 6 0.21ab
MeQ 0.23 6 0.08 0.11 6 0.04 0.18 6 0.01 0.14 6 0.02 0.002 6 0.00d 3.97 6 0.34a
PQ fed
PQ 9.86 6 2.33 0.77 6 0.21 0.32 6 0.16 0.10 6 0.04 0.01 6 0.00c 1.63 6 0.06bc
MePQ 17.4 6 3.88 0.81 6 0.23 0.16 6 0.07 0.17 6 0.06 0.02 6 0.00b 1.16 6 0.28c
ANOVA P value
Prenylation ,0.01 ,0.01 0.45 1.00 0.10 ,0.01
Methylation 0.13 0.45 0.26 0.25 ,0.01 0.83
Prenylation 3
methylation
0.12 0.39 0.59 0.57 ,0.01 ,0.01
1 Data are means 6 SEMs, n = 4. Data from kidney, muscle, and plasma were log transformed before ANOVA. Labeled means in a column
without a common letter differ, P , 0.05. MePQ, O-methylated prenyl quercetin; MeQ, O-methylated quercetin; PQ, 8-prenyl quercetin; Q,
quercetin.
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lymph fluid from rats via a thoracic lymph duct during the
experiment, PQ was detected in lymph fluid until 24 h after
injection (Fig. 3B). Because it was considered that PQmight pass
through the small intestine at 24 h after injection, PQ in the
lymph circulation came not only from intestinal absorption but
also from body fluids. Therefore, one must take into account the
contribution of the circulation of blood and lymph to the tissue
distribution of PQ.
The plasma total concentration reached 1.63 mmol/L (PQ)
and 1.16mmol/L (MePQ) after long-term feeding of PQ (Table 3).
MePQ may accumulate gradually in plasma by continuous
daily intake even though the intestinal absorption is limited by
a prenyl group (Fig. 1; Table 3). Although the concentrations of
PQ and MePQ in the blood circulation were lower than those of
Q and MeQ, simple diffusion into cells and association with the
surface membranes of cells were enhanced by prenylation
because of the higher hydrophobicity. The cellular uptake of
PQ was higher than that of Q in C2C12 cells (Fig. 2A). This
finding and our previous report on PN (8) confirm the elevation
of cellular uptake of flavonoids by the introduction of a prenyl
group. PQ seemed to efflux only slightly through ABC trans-
porters (which was different from the effect seen with Q),
because cellular accumulation of PQ was not appreciably
affected by an ATP inhibitor (Fig. 2B). Continuous intake for
a long time may be advantageous for effective accumulation of
prenyl flavonoids in target tissues. In fact, the amounts of PQ
and MePQ accumulated in the liver and kidney were much
higher than those of their nonmethylated forms (Table 3). Food
components are transported to the liver via the portal vein and to
the kidney via afferent arterioles. Q has been suggested to serve as
a substrate for a transporter, bilitranslocase (33). Certain flavo-
noids (e.g., Q or anthocyanins) have been found to be transported
into the liver or kidney through bilitranslocase (34,35). Taken
together, it is likely that prenylation of Q promotes its uptake into
the liver and kidney by increasing its affinity for a transporter
(e.g., bilitranslocase). Some flavonoid metabolites transferred to
the liver are moved into the bile for the enterohepatic circulation
(36) and finally excreted in the feces (37,38). Flavonoid metab-
olites are also excreted in urine (37,38). It seems that limitation
of the excretion causes accumulation in those tissues. Interest-
ingly, ABC transporters [multidrug resistance-associated pro-
tein-2 and/or multidrug resistance-associated protein-3] are
expressed in the liver and kidney (39) in a similar way to
enterocytes (30,32). Therefore, prenylation may lower efflux from
the liver and kidney by attenuating the transport activity of these
ABC transporters for flavonoids.
Q produces I (3#-O-methylated quercetin) and tamarixetin
(4#-O-methylated quercetin) by the action with catechol O-
methyltransferase (40). This reaction is regarded as detoxifica-
tion of catechol-type flavonoids, because the catechol group can
yield reactive oxygen species by a redox reaction to act as a
cytotoxic prooxidant (40,41). PQ also seems to produce 3#-O-
methylated PQ and 4#-O-methylated PQ.We could not distinguish
between these 2 O-methylated metabolites, because the O-
methylated metabolites were simultaneously eluted in the HPLC
chromatograms. O-methylated PQ was present in a greater
amount than non-O–methylated PQ in the brain (Table 3).
Therefore,O-methylation probably occurs preferentially during
PQ accumulation in the brain. In contrast, the occurrence
of O-methylation was not remarkable during Q accumulation
compared with PQ accumulation (Table 3). It seems that rapid
O-methylation is required to avoid the unfavorable prooxidant
effect of prenyl flavonoids, because prenyl flavonoids possess
greater biological potential than nonprenyl flavonoids.
In conclusion, we found that prenylation lowers the transport
of Q from enterocytes to the internal circulation, elevates its
incorporation from the circulation to tissues, and slows its efflux
from cells. Despite the lower bioavailability of this flavonoid in a
single dose, prenylation facilitates its accumulation in target
tissues in the case of continuous, long-term dietary intake. Thus,
substitution of the prenyl group may modulate the fate of
flavonoids from their absorption to excretion in the body.
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